These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18466878)

  • 1. Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment.
    Lejuez CW; Zvolensky MJ; Daughters SB; Bornovalova MA; Paulson A; Tull MT; Ettinger K; Otto MW
    Behav Res Ther; 2008 Jul; 46(7):811-8. PubMed ID: 18466878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between heroin use and anxiety sensitivity among inner-city individuals in residential drug use treatment.
    Lejuez CW; Paulson A; Daughters SB; Bornovalova MA; Zvolensky MJ
    Behav Res Ther; 2006 May; 44(5):667-77. PubMed ID: 16002042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in impulsivity and risk-taking propensity between primary users of crack cocaine and primary users of heroin in a residential substance-use program.
    Bornovalova MA; Daughters SB; Hernandez GD; Richards JB; Lejuez CW
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):311-8. PubMed ID: 16366761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence.
    Samet S; Fenton MC; Nunes E; Greenstein E; Aharonovich E; Hasin D
    Addiction; 2013 Jan; 108(1):115-23. PubMed ID: 22775406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novelty seeking as a predictor of treatment retention for heroin dependent cocaine users.
    Helmus TC; Downey KK; Arfken CL; Henderson MJ; Schuster CR
    Drug Alcohol Depend; 2001 Feb; 61(3):287-95. PubMed ID: 11164693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study.
    Marsden J; Eastwood B; Bradbury C; Dale-Perera A; Farrell M; Hammond P; Knight J; Randhawa K; Wright C;
    Lancet; 2009 Oct; 374(9697):1262-70. PubMed ID: 19800681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of anxiety and depression on completion/withdrawal status in patients admitted to substance abuse detoxification program.
    Araujo L; Goldberg P; Eyma J; Madhusoodanan S; Buff DD; Shamim K; Brenner R
    J Subst Abuse Treat; 1996; 13(1):61-6. PubMed ID: 8699544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users.
    Wang L; Min JE; Krebs E; Evans E; Huang D; Liu L; Hser YI; Nosyk B
    Int J Drug Policy; 2017 Nov; 49():32-40. PubMed ID: 28888099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with drug treatment dropout among injection drug users in Puerto Rico.
    Marrero CA; Robles RR; Colón HM; Reyes JC; Matos TD; Sahai H; Calderón JM; Shepard EW
    Addict Behav; 2005 Feb; 30(2):397-402. PubMed ID: 15621413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug use, HIV-related risk behaviors and dropout status of new admissions and re-admissions to methadone treatment.
    Deren S; Goldstein MF; Des Jarlais DC; Richman BL; Kang S; Flom PL
    J Subst Abuse Treat; 2001 Mar; 20(2):185-9. PubMed ID: 11306221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in impulsivity and sexual risk behavior among inner-city crack/cocaine users and heroin users.
    Lejuez CW; Bornovalova MA; Daughters SB; Curtin JJ
    Drug Alcohol Depend; 2005 Feb; 77(2):169-75. PubMed ID: 15664718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characteristics of 'new users' of cocaine and heroin unknown to treatment agencies: results from the Swiss Hidden Population Study.
    Kuebler D; Hausser D; Gervasoni JP
    Addiction; 2000 Oct; 95(10):1561-71. PubMed ID: 11070531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-time history of insomnia and hypersomnia symptoms as correlates of alcohol, cocaine and heroin use and relapse among adults seeking substance use treatment in the United States from 1991 to 1994.
    Dolsen MR; Harvey AG
    Addiction; 2017 Jun; 112(6):1104-1111. PubMed ID: 28127809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief motivational intervention at a clinic visit reduces cocaine and heroin use.
    Bernstein J; Bernstein E; Tassiopoulos K; Heeren T; Levenson S; Hingson R
    Drug Alcohol Depend; 2005 Jan; 77(1):49-59. PubMed ID: 15607841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydrug use among heroin users in Cleveland, OH.
    Bobashev G; Tebbe K; Peiper N; Hoffer L
    Drug Alcohol Depend; 2018 Nov; 192():80-87. PubMed ID: 30243143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spiritual/Religious experiences and in-treatment outcome in an inner-city program for heroin and cocaine dependence.
    Heinz A; Epstein DH; Preston KL
    J Psychoactive Drugs; 2007 Mar; 39(1):41-9. PubMed ID: 17523584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of anxiety sensitivity and difficulties in emotion regulation in posttraumatic stress disorder among crack/cocaine dependent patients in residential substance abuse treatment.
    McDermott MJ; Tull MT; Gratz KL; Daughters SB; Lejuez CW
    J Anxiety Disord; 2009 Jun; 23(5):591-9. PubMed ID: 19233609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation.
    Collins ED; Horton T; Reinke K; Amass L; Nunes EV
    J Subst Abuse Treat; 2007 Mar; 32(2):167-75. PubMed ID: 17306725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of borderline personality disorder on residential substance abuse treatment dropout among men.
    Tull MT; Gratz KL
    Drug Alcohol Depend; 2012 Feb; 121(1-2):97-102. PubMed ID: 21907503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heroin and cocaine craving and use during treatment: measurement validation and potential relationships.
    Heinz AJ; Epstein DH; Schroeder JR; Singleton EG; Heishman SJ; Preston KL
    J Subst Abuse Treat; 2006 Dec; 31(4):355-64. PubMed ID: 17084789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.